{
  "year" : 2011,
  "senateBillNo" : "A1775-2011",
  "billEvents" : [ {
    "eventDate" : 1294722000000,
    "eventText" : "referred to higher education",
    "billEventId" : "A1775-2011-1294722000000-referred+to+higher+education",
    "sobiReferenceList" : [ ],
    "luceneActive" : true,
    "luceneModified" : 0
  } ],
  "votes" : null,
  "sponsor" : {
    "id" : null,
    "position" : null,
    "fullname" : "Rosenthal",
    "branch" : null,
    "contactInfo" : null,
    "guid" : null
  },
  "title" : "Requires written notification where a pharmacist is substituting a generic version of a drug product by one manufacturer for a generic version of a drug product by another manufacturer",
  "summary" : "Requires written notification to patients where a pharmacist is substituting a generic version of a drug product by one manufacturer for a generic version of a drug product by another manufacturer. ",
  "currentCommittee" : null,
  "sameAs" : null,
  "lawSection" : "Education Law",
  "previousVersions" : [ "A10041-2009" ],
  "coSponsors" : null,
  "pastCommittees" : null,
  "fulltext" : "\n                           S T A T E   O F   N E W   Y O R K\n       ________________________________________________________________________\n\n                                         1775\n\n                              2011-2012 Regular Sessions\n\n                                 I N  A S S E M B L Y\n\n                                   January 11, 2011\n                                      ___________\n\n       Introduced  by  M.  of  A.  ROSENTHAL  --  read once and referred to the\n         Committee on Higher Education\n\n       AN ACT to amend the education law,  in  relation  to  requiring  written\n         notification  to patients where a pharmacist is substituting a generic\n         version of a drug product by one manufacturer for a generic version of\n         a drug product by another manufacturer\n\n         THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-\n       BLY, DO ENACT AS FOLLOWS:\n\n    1    Section  1. Section 6816-a of the education law is amended by adding a\n    2  new subdivision 3 to read as follows:\n    3    3. A PHARMACIST SHALL PROVIDE WRITTEN NOTIFICATION TO A PATIENT IF  HE\n    4  OR  SHE  IS  SUBSTITUTING  A  GENERIC  VERSION  OF A DRUG PRODUCT BY ONE\n    5  MANUFACTURER FOR A GENERIC VERSION OF A DRUG PRODUCT BY ANOTHER MANUFAC-\n    6  TURER.\n    7    S 2. This act shall take effect on the sixtieth  day  after  it  shall\n    8  have become a law.\n\n\n\n\n\n\n        EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets\n                             [ ] is old law to be omitted.\n                                                                  LBD01778-01-1\n",
  "memo" : null,
  "law" : null,
  "actClause" : "AN ACT to amend the education law, in relation to requiring written notification to patients where a pharmacist is substituting a generic version of a drug product by one manufacturer for a generic version of a drug product by another manufacturer ",
  "sortIndex" : -1,
  "latestAmendment" : null,
  "sobiReferenceList" : [ "SOBI.D110111.T164725.TXT", "SOBI.D110112.T114459.TXT" ],
  "luceneActive" : true,
  "luceneModified" : 1294850699713
}